Apex Healthcare Berhad (7090.KL)

MYR 2.0

(-5.66%)

EBITDA Summary of Apex Healthcare Berhad

Apex Healthcare Berhad's latest annual EBITDA in 2023 was 441.93 Million MYR , up 222.77% from previous year.
Apex Healthcare Berhad's latest quarterly EBITDA in 2024 Q2 was 34.54 Million MYR , up 10.3% from previous quarter.
Apex Healthcare Berhad reported an annual EBITDA of 137.57 Million MYR in 2022, up 48.47% from previous year.
Apex Healthcare Berhad reported an annual EBITDA of 92.6 Million MYR in 2021, up 5.25% from previous year.
Apex Healthcare Berhad reported a quarterly EBITDA of 34.54 Million MYR for 2024 Q2, up 10.3% from previous quarter.
Apex Healthcare Berhad reported a quarterly EBITDA of 339.11 Million MYR for 2023 Q2, up 890.37% from previous quarter.

Annual EBITDA Chart of Apex Healthcare Berhad (2023 - 2019)

Historical Annual EBITDA of Apex Healthcare Berhad (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	441.93 Million MYR	222.77%
2022	137.57 Million MYR	48.47%
2021	92.6 Million MYR	5.25%
2020	87.76 Million MYR	22.36%
2019	71.56 Million MYR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	31.32 Million MYR	-6.43%
2024 Q2	34.54 Million MYR	10.3%
2023 Q2	339.11 Million MYR	890.37%
2023 Q4	33.47 Million MYR	-4.67%
2023 FY	- MYR	222.77%
2023 Q1	34.24 Million MYR	10.78%
2023 Q3	35.11 Million MYR	-89.65%
2022 Q3	27.86 Million MYR	0.0%
2022 FY	- MYR	48.47%
2022 Q4	30.9 Million MYR	10.95%
2021 FY	- MYR	5.25%
2020 FY	- MYR	22.36%
2019 FY	- MYR	0.0%

Peer EBITDA Comparison of Apex Healthcare Berhad

Name	EBITDA	EBITDA Difference
Artroniq Berhad	-695 Thousand MYR	63688.436%
QES Group Berhad	33.26 Million MYR	-1228.582%
Optimax Holdings Berhad	28.58 Million MYR	-1446.054%
Pharmaniaga Berhad	7.34 Million MYR	-5914.421%